XTP3-B Activators
XTP3-B Activators are a specialized category of chemical compounds that specifically target and enhance the activity of the protein XTP3-B, a transmembrane protein implicated in the quality control system within the endoplasmic reticulum. These activators are known for their precise action on the cellular mechanisms that govern protein folding and degradation. One notable mechanism through which these activators function is by stabilizing the interaction between XTP3-B and its substrate proteins, thereby facilitating the correct folding of nascent polypeptides. This stabilization is crucial as it prevents the premature degradation of potentially viable proteins within the cell. Another way these activators work is by modulating the endoplasmic reticulum-associated degradation (ERAD) pathway. By enhancing the selectivity of XTP3-B, these activators ensure that only misfolded proteins are targeted for degradation, thereby maintaining cellular homeostasis and protein quality control.
In addition to the stabilization of protein-substrate interactions, XTP3-B Activators also influence the upstream signaling pathways that regulate the expression of XTP3-B itself. By promoting the transcriptional upregulation of the gene encoding XTP3-B, these chemicals ensure an adequate level of the protein is present in the endoplasmic reticulum to handle the load of misfolded proteins. Furthermore, they may interact with other molecular chaperones and folding enzymes, creating a more efficient network for protein quality control. The precise molecular interactions between XTP3-B Activators and these pathways are complex and involve a series of phosphorylation events, leading to enhanced proteostasis. These activators, through their concerted action on protein folding and degradation pathways, underscore the critical balance within cellular processes that XTP3-B helps to maintain. Their role is foundational in the maintenance of cellular function, emphasizing the importance of XTP3-B in overall protein management within the endoplasmic reticulum.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, leading to an increase in cAMP levels. Elevated cAMP activates PKA, which can phosphorylate and enhance the activity of XTP3-B, as part of its role in quality control during protein folding. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration. This rise in calcium levels can activate calcium-dependent protein kinases, which may phosphorylate XTP3-B, enhancing its functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate a range of substrates including XTP3-B, potentially enhancing its activity in cellular signaling pathways. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels, thereby activating PKA. PKA can subsequently phosphorylate XTP3-B, thereby enhancing its function. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates cell differentiation and proliferation. It can influence the activity of XTP3-B by modulating the cellular context in which XTP3-B operates, indirectly enhancing its function. | ||||||
(±)-S-Nitroso-N-acetylpenicillamine | 79032-48-7 | sc-200319B sc-200319 sc-200319A | 10 mg 20 mg 100 mg | $74.00 $114.00 $374.00 | 18 | |
SNAP releases nitric oxide, which can modulate the activity of various signaling molecules, including kinases that may phosphorylate and activate XTP3-B. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, which activates calcium-dependent signaling pathways and could lead to the phosphorylation and activation of XTP3-B. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cAMP analog that activates PKA. This activation of PKA can lead to phosphorylation and enhancement of XTP3-B's activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels which can activate signaling pathways involving XTP3-B. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain inhibits the Na+/K+ ATPase pump, altering ionic gradients, which can affect signaling pathways and potentially enhance the activity of XTP3-B through indirect effects on cellular homeostasis. | ||||||